Navigation Links
TorreyPines Therapeutics Appoints Evelyn Graham Chief Executive Officer and a Member of the Board of Directors
Date:11/12/2008

LA JOLLA, Calif., Nov. 12 /PRNewswire/ -- TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) today announced that the Board of Directors has appointed Evelyn Graham as the Company's Chief Executive Officer and as a member of the Company's Board of Directors. Ms. Graham had been serving as the Company's acting Chief Executive Officer since September 1, 2008.

"Ev has done an impressive job as acting CEO in managing the transition of our company and building a platform for the future," said Peter Davis, Chairman of the TorreyPines Board of Directors. "We are delighted that she has agreed to become CEO and a member of the Board at a time when TorreyPines is completing important clinical trials that hold promise for the company's future. With her considerable drug development experience as well as global senior management roles, she has the right mix of skills and experience to successfully lead the Company in meeting its strategic objectives."

"I am excited by this opportunity and look forward to continuing to work with TorreyPines' talented management team and dedicated employees," said Ms. Graham.

Ms. Graham joined TorreyPines in 2004 as Vice President, Development. She was then promoted to Vice President, Corporate Development in 2005, Chief Operating Officer in 2006 and acting Chief Executive Officer in September 2008. Prior to joining TorreyPines Ms. Graham was Executive Director, Development Operations at Purdue Pharma from 2000 to 2003. From 1998 to 2000, she was Senior Vice President of Business Development at Ingenix Pharmaceutical Services, a division of UHG, and served as Vice President of Clinical Operations at Worldwide Clinical Trials, prior to its acquisition by UHG. Previously, Ms. Graham held positions in oper
'/>"/>

SOURCE TorreyPines Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments
2. TorreyPines Therapeutics Sells Alzheimers Disease Genetics Program to Eisai
3. TorreyPines Therapeutics Begins Dosing in a Phase I Multiple Dose Clinical Trial of NGX426, Oral Prodrug of Tezampanel
4. TorreyPines Therapeutics Reports Successful End-of-Phase II Meeting With FDA for Tezampanel
5. TorreyPines Therapeutics Strategically Repositions as Development Company Focusing on Three Versatile Lead Compounds
6. TorreyPines Therapeutics Receives NASDAQ Deficiency Notice
7. TorreyPines Therapeutics to Present Tezampanel Phase IIb Clinical Data for Acute Migraine at 50th Annual Scientific Meeting of the American Headache Society
8. TorreyPines Therapeutics to Host First Quarter 2008 Results Conference Call and Webcast
9. TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights
10. TorreyPines Therapeutics Initiates Phase II Study of Muscarinic Agonist NGX267 for Treatment of Xerostomia
11. TorreyPines Therapeutics to Present at Susquehanna Financial Groups Second Annual SIGnificant Options in Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... of engineers from Singapore has successfully piloted the ... satellite communications. , With the weight of payloads ... a lightweight, low power-consuming, wireless communication system to ... always been a challenge for system designers. , ... of Nanyang Technological University in Singapore launched VELOX-I, ...
(Date:8/26/2014)... , Aug. 26, 2014  ViveBio, LLC a ... collection, stabilization and transportation, announced today that it ... Services, LLC (LPS) of Knoxville, Tennessee ... in the United States . ... of ambient temperature dried biological specimen transport systems.  ...
(Date:8/26/2014)... August 26, 2014 Vycom announced today ... which specializes in chemical process equipment, has selected its ... University’s Facility for Rare Isotope Beams (FRIB). This ... cleaning line made with Vycom’s Flametec PVC-C and Kytec ... the essential parts of FRIB’s linear accelerator (known as ...
(Date:8/26/2014)... CITY, Calif. , Aug. 26, 2014 /PRNewswire/ ... development and commercialization of oncology diagnostic products, has ... as a 2015 Technology Pioneer . As ... is one of 24 companies across a wide ... prestigious accolade. Guardant360 ® , ...
Breaking Biology Technology:ZigBee in the Sky 2ViveBio and Laboratory Procurement Services Sign Agreement for Distribution of the ViveST Line of Products 2Modutek Selects Vycom’s Flametec Materials for Michigan State University’s Superconductor Equipment 2Modutek Selects Vycom’s Flametec Materials for Michigan State University’s Superconductor Equipment 3Guardant Health Named a 2015 Technology Pioneer by World Economic Forum 2
... FRANCISCO, Jan. 9, 2012 EVENT:Live Press Briefing on ... 2012 TIME:10 a.m. – 10:45 a.m. PT presentation ... companies: NuVasive (NASDAQ: NUVA ), Omniox ... BayBio, California Healthcare Institute and PwC USWHERE:Grand Hyatt ...
... Exagen Diagnostics, Inc., a specialty focused molecular ... for rheumatologists and gastroenterologists, announced today the launch of ... (Systemic Lupus Erythematosus). Avise SLE is a ... rheumatic diseases to help establish the most accurate SLE ...
... FRANCISCO, Calif., Jan. 9, 2012   Veracyte, Inc ... field of molecular cytology, today announced that Palmetto ... has established coverage for the company,s Afirma Gene ... This means that Veracyte,s genomic test is now ...
Cached Biology Technology:Live Press Briefing on Findings of Biomedical Industry CEO Survey 2Live Press Briefing on Findings of Biomedical Industry CEO Survey 3Exagen Diagnostics Launches Cutting-Edge Lupus Diagnostic 2Veracyte Announces Medicare Coverage for Its Afirma® Gene Expression Classifier for Improved Thyroid Nodule Diagnosis 2Veracyte Announces Medicare Coverage for Its Afirma® Gene Expression Classifier for Improved Thyroid Nodule Diagnosis 3
(Date:8/26/2014)... increased risk of autism among children of women ... the known increased risk associated with severe maternal ... publication in Molecular Psychiatry , investigators from ... a diagnosis of autism spectrum disorder was more ... during pregnancy than in those with no prenatal ...
(Date:8/26/2014)... the Ethical Treatment of Animals (PETA) and the PETA ... Prague this week at the 9th World Congress on ... original research on alternatives to the use of animals ... studies identifying problems with current laboratory oversight systems. , ... 24 to 28, 2014, PETA and PISC will present ...
(Date:8/26/2014)... , August 26, 2014 ... von Oxygen Forensic Passware Analyst bekannt, einem ... preisgekrönten Erfassungs- und Analysetools von Oxygen mit ...     Das neue Tool kombinierte ... einem einzigen nahtlosen Ablauf. Das neu hinzugekommene ...
Breaking Biology News(10 mins):Study calls into question link between prenatal antidepressant exposure and autism risk 2Study calls into question link between prenatal antidepressant exposure and autism risk 3Oxygen Forensic Passware Analyst erfasst geschützte Mobilgerätedaten 2
... it infects the lungs, the Legionnaire,s bacterium Legionella ... is particularly ingenious: it infiltrates deliberately into cells of ... proteins which then interfere in the normal cellular processes. ... in Dortmund have now discovered how Legionella ...
... Cardiff University researcher has secured a highly sought-after Leadership award ... Dr Paola Borri, Cardiff School of Biosciences, is a physicist ... life and physical sciences Now, she has won a ... for the next five years. This will support her own ...
... playing a significant role in today,s news, including hot-button ... diseases and dozens of other critical concerns. Faced with ... for excellent science teachers who can prepare the next ... with these and other scientific challenges ahead. Producing ...
Cached Biology News:Hijacked supplies for pathogens 2Boost for world-leading microscopy project 2Getting young scientists into the science teacher pipeline 2Getting young scientists into the science teacher pipeline 3
... Have you bought a Perkin Elmer UltraVIEW system ... the Andor iXon and iQ software? No problem. ... upgrade. You keep your existing microscope, lasers, Sutter ... customise it to work with our precision controller ...
...
... is a 96-well ELISA-compatible plate (containing 12 x ... Monoclonal Antibody is immobilized by a method that ... the tail fiber protein of the T7 bacteriophage. ... 10 9 phage per well and low ...
... The TRAPeze RT Telomerase Detection ... in vitro assay for the ... quantification of telomerase activity. It ... TRAPeze assay and adds the ...
Biology Products: